不孕症患者在COVID-19疫情前后对人类胚胎基因编辑与全基因组测序的接受度
该研究通过2018年4月至6月及2021年7月至12月的书面调查,比较不孕症患者对可遗传性基因编辑(HGE)和胚胎植入前遗传学检测全基因组测序(PGT-WGS)的接受度变化。2021年与2018年分别有172例和469例完成问卷(应答率90%和91%)。结果显示,疫情后对HGE的接受度显著提高,而对PGT-WGS的支持度相似。
要点
- 2021年较2018年更多受访者对HGE持积极态度,包括治疗和增强适应症。
- 2021年85%受访者愿用HGE生育健康亲生子女,2018年为77%。
- 2021年对PGT-WGS预防成年疾病的支持度与2018年相似。
核心结论
- COVID-19疫情后,对HGE的接受度显著增加,但对PGT-WGS的接受度未增加。
- 疫情可能促成了这一变化,但确切原因未知,需进一步研究。
- HGE接受度增加是否反映对新兴生物医学技术整体接受度提高,需进一步研究。
研究设计与样本
- 2018年4月至6月及2021年7月至12月在一家大学附属不孕症诊所开展的书面问卷调查。
- 问卷评估对HGE用于特定治疗或遗传「增强」适应症的接受度,及对PGT-WGS预防成年疾病的接受度。
- 2021年172例、2018年469例完成问卷,应答率分别为90%和91%。
主要发现
- 2021年较2018年,受访者更可能使用HGE与自身配子生育健康子女(85% vs 77%)。
- 2021年较2018年,受访者更可能使用HGE降低成年起病多基因疾病风险(78% vs 67%)。
- 2021年较2018年,受访者更可能使用HGE增加预期寿命(55% vs 40%)、智力(34% vs 26%)和创造力(33% vs 24%)。
- 2021年组中15%因COVID-19对HGE态度更积极,不到1%态度更消极。
- 2021年与2018年对PGT-WGS的支持度相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 疫情可能促成了HGE接受度变化,但确切原因未知,需进一步研究。
- HGE接受度增加是否反映对新兴生物医学技术整体接受度提高,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Has acceptance of heritable genome editing (HGE) and whole genome sequencing for preimplantation genetic testing (PGT-WGS) of human embryos changed after the onset of COVID-19 among infertility patients? DESIGN: A written survey conducted between April and June 2018 and July and December 2021 among patients at a university-affiliated infertility practice. The questionnaire ascertained the acceptance of HGE for specific therapeutic or genetic 'enhancement' indications and of PGT-WGS to prevent adult disease. RESULTS: In 2021 and 2018, 172 patients and 469 patients (response rates: 90% and 91%, respectively) completed the questionnaire. In 2021, significantly more participants reported a positive attitude towards HGE, for therapeutic and enhancement indications. In 2021 compared with 2018, respondents were more likely to use HGE to have healthy children with their own gametes (85% versus 77%), to reduce disease risk for adult-onset polygenic disorders (78% versus 67%), to increase life expectancy (55% versus 40%), intelligence (34% versus 26%) and creativity (33% versus 24%). Fifteen per cent of the 2021 group reported a more positive attitude towards HGE because of COVID-19 and less than 1% a more negative attitude. In contrast, support for PGT-WGS was similar in 2021 and 2018. CONCLUSIONS: A significantly increased acceptance of HGE was observed, but not of PGT-WGS, after the onset of COVID-19. Although the pandemic may have contributed to this change, the exact reasons remain unknown and warrant further investigation. Whether increased acceptability of HGE may indicate an increase in acceptability of emerging biomedical technologies in general needs further investigation.
引用
- Neuhausser WM, Fouks Y, Lee SW, et al. Acceptance of genetic editing and of whole genome sequencing of human embryos by patients with infertility before and after the onset of the COVID-19 pandemic. Reprod Biomed Online. 2023. PMID: 37127437. doi:10.1016/j.rbmo.2023.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。